Simplex Trading, LLC Bristol Myers Squibb CO Transaction History

Simplex Trading, LLC

$175 Billion
Q2 2025

A detailed history of Simplex Trading, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Simplex Trading, LLC holds 64,693 shares of BMY stock, worth $2.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,693

Previous 188,899 65.75%

Holding current value

$2.98 Million

Previous $11.5 Million 74.01%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$44.12 - $59.6 $5.48 Million - $7.4 Million	-124,206 Reduced 65.75%	64,693 $2.99 Million
Q1 2025 May 12, 2025	SELL	$53.9 - $63.11 $7.96 Million - $9.32 Million	-147,729 Reduced 43.88%	188,899 $11.5 Million
Q4 2024 Feb 11, 2025	SELL	$51.92 - $59.94 $750,659 - $866,612	-14,458 Reduced 4.12%	336,628 $19 Million
Q3 2024 Nov 08, 2024	SELL	$39.66 - $51.75 $8.21 Million - $10.7 Million	-206,925 Reduced 37.08%	351,086 $18.2 Million
Q2 2024 Jul 25, 2024	BUY	$40.25 - $52.99 $2.18 Million - $2.88 Million	54,263 Added 10.77%	558,011 $23.2 Million
Q1 2024 Apr 25, 2024	BUY	$47.98 - $54.4 $24.2 Million - $27.4 Million	503,748 New	503,748 $27.3 Million
Q3 2023 Nov 01, 2023	BUY	$57.89 - $64.73 $5.4 Million - $6.04 Million	93,234 Added 104.34%	182,593 $10.6 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $5.69 Million - $6.32 Million	89,359 New	89,359 $5.71 Million
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $1.6 Million - $1.89 Million	23,361 Added 12.45%	210,946 $15.2 Million
Q3 2022 Nov 04, 2022	SELL	$0.13 - $76.84 $6,951 - $4.11 Million	-53,474 Reduced 22.18%	187,585 $13.3 Million
Q2 2022 Aug 03, 2022	BUY	$72.62 - $79.98 $17.5 Million - $19.3 Million	240,884 Added 137648.0%	241,059 $18.6 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $10 Million - $12 Million	-162,939 Reduced 99.89%	175 $12,000
Q4 2021 Feb 23, 2022	BUY	$53.63 - $62.52 $3.49 Million - $4.06 Million	65,017 Added 66.28%	163,114 $10.2 Million
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $4,141 - $4,851	-70 Reduced 0.07%	98,097 $6.53 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $955,085 - $1.04 Million	15,427 Added 18.65%	98,167 $6.56 Million
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $2.02 Million - $2.27 Million	-33,996 Reduced 29.12%	82,740 $5.22 Million
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $5.45 Million - $6.18 Million	94,467 Added 424.21%	116,736 $7.24 Million
Q3 2020 Oct 14, 2020	SELL	$57.43 - $63.64 $9.59 Million - $10.6 Million	-167,000 Reduced 88.23%	22,269 $1.34 Million
Q2 2020 Jul 13, 2020	SELL	$54.82 - $64.09 $9.14 Million - $10.7 Million	-166,733 Reduced 46.83%	189,269 $11.1 Million
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $7.62 Million - $11.1 Million	164,287 Added 85.69%	356,002 $19.8 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $9.43 Million - $12.3 Million	191,715 New	191,715 $0
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $8.63 Million - $10.2 Million	-201,734 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$44.62 - $49.34 $3.91 Million - $4.32 Million	87,641 Added 76.82%	201,734 $9.15 Million
Q1 2019 Apr 18, 2019	BUY	$45.12 - $53.8 $440,912 - $525,733	9,772 Added 9.37%	114,093 $0
Q4 2018 Jan 16, 2019	BUY	$48.76 - $63.23 $2.05 Million - $2.65 Million	41,956 Added 67.27%	104,321 $5.42 Million
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $2.21 Million - $2.49 Million	-40,046 Reduced 39.1%	62,365 $3.87 Million
Q2 2018 Jul 30, 2018	SELL	$50.53 - $62.98 $751,229 - $936,323	-14,867 Reduced 12.68%	102,411 $5.67 Million
Q1 2018 Apr 26, 2018	BUY	$59.92 - $68.98 $7.03 Million - $8.09 Million	117,278 New	117,278 $7.42 Million

Others Institutions Holding BMY

# of Institutions

2,668

Shares Held

1.64B

Call Options Held

22.5M

Put Options Held

25.3M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $98B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Bristol Myers Squibb CO Transaction History